🕒 Wednesday 21 October 2026 Wed, 21 Oct 2026

Sierra Nevada Gold has started a 25,000-metre second-phase drilling campaign at its As Safra copper-gold project in Saudi Arabia, with the first assay results due in November. The company is directing capital and management attention to Saudi Arabia while exploring commercial options for its Nevada portfolio.

Skellerup says FY27 has begun strongly, with first-quarter net profit after tax up 15% on the prior comparative period. The NZX-listed industrial products maker is forecasting full-year NPAT of $67 million to $72 million, while warning that geopolitical unrest and higher costs could weigh on demand.

Scorpion Minerals has outlined a materially larger open-pit opportunity at Old Prospect, with an optimisation identifying 16,159 ounces of gold from two pits. The result is an early development signal, but it depends on a A$6,000 per ounce gold assumption and is not yet a feasibility study or ore reserve.

SenSen Networks has opened FY27 with record quarterly customer cash receipts of A$5.3 million, 17% annualised recurring revenue growth and positive operating cash flow. The ASX-listed AI enforcement software company also secured A$2.6 million in new and expansion contracts, although converting those wins into recurring revenue remains the next test.

CD Private Equity Fund II’s underlying investment vehicle has agreed to sell four mature private equity fund interests for approximately US$6.1 million. The sale is priced at 64% of reported NAV but could lead to a future distribution to CD2 unitholders.

InVert Graphite has secured outright ownership of Curtin University’s RapidPulse technology while advancing a 2.56 million tonne contained graphite resource at Kumba. The company ended September with A$3.2 million in cash, giving it an estimated 5.5 quarters of funding at the latest spending rate.

Sarytogan Graphite’s upstream DFS supports a 50,000-tonne-a-year Kazakhstan graphite operation with a pre-tax NPV8 of US$132.7 million, but the company remains unfunded and without binding offtake. Trading in its shares has also been suspended while it seeks Western Australian court orders over an inadvertently unlodged options prospectus.

Golden Dragon Mining has finished an approximately 2,800-metre RC drilling program at its Cue Gold Project after reporting high-grade results and a more than 3-kilometre gold corridor. The company also ended the September quarter with A$4.11 million in cash following a strategic A$2.2 million investment from Chengtun Gold.

BSA has signed a binding agreement to acquire 100% of Eonetics, bringing tethered-drone communications technology into its national infrastructure services business. The transaction remains conditional on due diligence, regulatory clearance and shareholder approval.

MA Financial delivered strong third-quarter growth across lending, asset management and advisory, while warning that residential property credit conditions have forced a temporary redemption suspension. The group still expects underlying FY26 EPS to be materially higher than FY25.

Kantra Copper delivered a fifth consecutive quarter of higher copper production, with net group cash flow rising 72% to $14.2 million and cash reaching $44.1 million. The ASX-listed miner also began Emily Star development and moved its Coburn project closer to a pre-feasibility study.

Maronan Metals has completed more than 15,000 metres of a 40,000-metre infill program and is preparing to accelerate work at its Queensland project with a proposed A$20 million placement. The funding remains subject to shareholder approval, while a new chief executive is due to take charge in November.

Star Minerals has completed mining to 445mRL at Tumblegum South, with mineralised material stockpiled and awaiting transport to the mill. The next test is whether drilling, processing and a cash balance covering an estimated 2.09 quarters can carry the project into production.

Genetic Signatures and Microba Life Sciences have agreed in principle to revise their proposed merger, reducing Microba shareholders’ post-deal ownership from about 67% to 60%. The change improves the position of existing GSS shareholders, but the transaction remains non-binding and subject to multiple approvals.

Service Stream has reported higher margins, earnings and dividends for FY26, while its newly mobilised Defence operations are positioned to contribute more meaningfully in FY27. The company enters the new year with $8.2 billion of work in hand, a net cash balance sheet and a positive but non-specific growth outlook.

Orcoda has opened FY27 with unaudited quarterly revenue of $6.2 million, up 63% from the previous quarter, while annual recurring revenue reached approximately $14.7 million. The strongest contribution came from its Resource and Infrastructure division, where revenue more than doubled as the company reduced reliance on a single major customer.

Woodside delivered a stronger third quarter as production rose 12% and operating revenue reached US$4.281 billion. Scarborough is now 99% complete and remains on track for its first LNG cargo in Q4, while the company moves to reduce its Beaumont New Ammonia investment.

Cleo Diagnostics’ prototype ovarian cancer screening test met or exceeded every predefined performance target in a 247-person proof-of-concept study, including among 62 Stage I cases. The result moves the program into larger bridging and expanded studies, but it remains retrospective evidence rather than a validated screening test.

Findi says it has not secured financing or restructuring terms acceptable to the relevant parties, while its cash runway remains short and its ASX suspension continues. The company cannot provide a date for lodging its FY2026 audited accounts or Annual Report.

Trek Metals has confirmed a shallow, high-grade manganese discovery at Kuro in Western Australia, with 38 of 72 Phase 1 holes returning significant intercepts. Follow-up drilling is complete, while the company has also secured an option over a second manganese project in Arizona.

Perpetual's Corporate Trust division reached a record A$1.4 trillion in funds under administration, but that progress was outweighed by A$9.6 billion in first-quarter Asset Management outflows. Wealth Management remained stable as the proposed Bain Capital sale moved towards a targeted late-2026 completion.

BLS Pharmaceuticals has started FY27 with its strongest quarter on record, reporting A$26.7 million in unaudited revenue and positive operating cash flow. The company reaffirmed its A$105 million to A$115 million revenue guidance while continuing to invest in Australian and Scottish manufacturing capacity.

Invion has secured two financing arrangements that could cover up to approximately 85% of its clinical trial costs, providing support for its skin cancer and planned anogenital cancer programs. The funding comes with potential dilution, 16% interest and conditions that leave the actual amount available dependent on drawdowns and R&D tax refunds.

Jupiter Energy reported approximately US$1.925 million in unaudited third-quarter oil sales, while cash reserves fell to A$172,000 against US$13.87 million of debt. All expected fourth-quarter production has been sold on a prepaid basis, providing near-term operating support but leaving little room for disruption.